Skip to main content
SpringerLink
Log in

Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries”

  • Letter to the Editor
  • Published:
Drugs Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 01 December 2022

The Original Article was published on 01 December 2022

The Original Article was published on 01 July 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Denning DW. Comment on: “Global consumption trend of antifungal agents in humans from 2008 to 2018: data from 65 middle- and high-income countries.” Drugs. 2022. https://doi.org/10.1007/s40265-022-01811-2.

    Article  Google Scholar 

  2. Pathadka S, Yan VKC, Neoh CF, et al. Global consumption trend of antifungal agents in humans from 2008 to 2018: data from 65 middle- and high-income countries. Drugs. 2022;82(11):1193–205.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Swathi Pathadka and Vincent K. C. Yan contributed equally.

Authors and Affiliations

  1. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 1/F, 5 Sassoon Road, Pokfulam, Hong Kong SAR, China

    Swathi Pathadka, Vincent K. C. Yan & Esther W. Chan

  2. Eli Lilly Services Pvt Ltd, Bangalore, India

    Swathi Pathadka

  3. Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

    Chin Fen Neoh & Monica A. Slavin

  4. National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

    Chin Fen Neoh & Monica A. Slavin

  5. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia

    Chin Fen Neoh

  6. Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia

    Chin Fen Neoh

  7. College of Pharmacy, QU Health, Qatar University, Doha, Qatar

    Daoud Al-Badriyeh

  8. Pharmacy Department, Grampians Health, Ballarat, VIC, Australia

    David C. M. Kong

  9. National Centre for Antimicrobial Stewardship, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia

    David C. M. Kong

  10. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia

    David C. M. Kong

  11. Immunocompromised Host Service, Royal Melbourne Hospital, Melbourne, VIC, Australia

    Monica A. Slavin

  12. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China

    Benjamin J. Cowling

  13. Division of Infectious Diseases, Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China

    Ivan F. N. Hung

  14. Research Department of Practice and Policy, UCL School of Pharmacy, London, UK

    Ian C. K. Wong

  15. Aston Pharmacy School, Aston University, Birmingham, UK

    Ian C. K. Wong

  16. Laboratory of Data Discovery for Health, Pokfulam, Hong Kong SAR, China

    Ian C. K. Wong & Esther W. Chan

  17. Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China

    Esther W. Chan

  18. The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China

    Esther W. Chan

Authors
  1. Swathi Pathadka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent K. C. Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chin Fen Neoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daoud Al-Badriyeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David C. M. Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Monica A. Slavin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Benjamin J. Cowling
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ivan F. N. Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ian C. K. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Esther W. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esther W. Chan.

Ethics declarations

Funding

The original study [2] was supported through internal seed funding from the Li Ka Shing Faculty of Medicine, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflicts of interest

EWC has received research grants from the Research Grants Council (RGC, Hong Kong), Narcotics Division of the Security Bureau of the Government of the Hong Kong SAR, Research Fund Secretariat of the Food and Health Bureau, National Natural Science Fund of China, Wellcome Trust, Bayer, Bristol-Myers Squibb, Pfizer, Janssen, Amgen, and Takeda, outside the submitted work. ICKW has received research grants from Research Grants Council (RGC, Hong Kong), Innovative Medicines Initiative (IMI), Shire, Janssen-Cilag, Eli-Lily, Pfizer, Bayer, and grants from European Union FP7 program, outside the submitted work. DCMK has sat on advisory boards for Becton Dickinson Pty Ltd and Merck Sharp & Dohme (MSD), and received financial support from MSD and F2G, outside the submitted work. MS has received grants from Gilead Sciences, Merck, F2G, and Pfizer unrelated to the submitted work. BJC has received funding from Sanofi Pasteur and Roche, outside the submitted work. The other author(s) declare no conflicts of interest.

Availability of data and materials

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pathadka, S., Yan, V.K.C., Neoh, C.F. et al. Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries”. Drugs 82, 1755–1756 (2022). https://doi.org/10.1007/s40265-022-01812-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-022-01812-1

Search

Navigation